fashion -WSS

fashion

author：leisure time 2025-09-06 04:17:38 - browse：13

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Medicare Advantage enrollment grows 7.1% to 33.4 million people

WSS

H5N1 bird flu outbreak: Second human case reported, in Michigan

H5N1 bird flu outbreak: Second human case reported, in Michigan

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Questions and answers about ramping up H5N1 bird flu vaccine

Scrutiny of post

In 'major milestone,' FDA approves first cell therapy for solid tumors

hotspot

fashion

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

FDA warns medical device makers about rise in fabricated data

As demand for Covid shots wanes, Moderna seeks its next success

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Affirmative action in medical school literally saved lives

Eyeing GLP

Medicare proposal to cover medical devices draws a mixed reaction

FDA poised to publish guidelines for clinical trial diversity

Malaria cases in Florida and Texas: Here’s what you need to know

At flashy new research hub, AstraZeneca lays out ambitious growth goals

hotspot

Measles policy set amid Florida outbreak alarms vaccine proponents

H5N1 virus can be tracked in retail milk, scientists say

Opioid cravings were reduced by anti

FDA poised to publish guidelines for clinical trial diversity

New study raises questions about niacin and heart health

Weight loss drugs aren’t covered by Obamacare. That may change

explore

knowledge

hotspot

leisure time